Position in OCGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,040,604
-$1,067,737 QoQ
Shares Held
1,127,406
-51.0% QoQ
Ownership
0.333%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OCGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $9,665,383,874 across 365 Biotechnology names. OCGN ranks #210 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,902 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,133 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,807 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,070 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,387 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,920 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,875 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,621 |
All Filings in OCGN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,040,604 | 1,127,406 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,108,341 | 2,302,475 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $159,267 | 97,710 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $860,440 | 887,052 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $424,079 | 600,679 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $664,806 | 825,847 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $925,274 | 932,737 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,177,132 | 759,440 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $4,276,505 | 2,607,625 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $38,373 | 70,669 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $601,279 | 704,900 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $2,008,779 | 1,545,215 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $3,549,177 | 1,993,920 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $3,581,296 | 1,577,664 | Shares | Defined | 2022-08-18 | |
| 2022-03-31 | $3,237,061 | 980,928 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,003,829 | 220,622 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $1,618,364 | 225,399 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $1,867,375 | 232,550 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,217,396 | 326,568 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $20,602 | 11,258 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||